Exit this survey

29th Annual TNP Conference Workshop F23 Evaluation - Management of Chronic Kidney Disease 

Speaker: Denise K. Link
Friday, September 8, 2017

Question Title

F23: As a result of my participation in the Management of Chronic Kidney Disease and Complications in Primary Care, I am better to:

  Strongly Disagree Disagree Agree Strongly Agree
Understand definition of CKD and new prognosis staging based upon KDIGO (Kidney Disease Improving Global Outcomes 2012)
Define treatment goals in management of CKD based upon latest evidence based guidelines from KDIGO: lowering BP and proteinuria including pharmacological treatments (RX)
Discuss/Debate/Interpret the most recent CKD blood pressure guidelines from JNC 8 and KDIGO (RX)
Interpret new FDA guidelines for metformin usage in CKD and Type 2 DM population (RX)
Understand how to manage the complications associated with pharmacology treatment of CKD including hperkalemia, fluid overload, metabolic acidosis, and proteinuria using diuretics (RX)

Question Title

The teaching methods used were appropriate to the objectives.

Question Title

Denise K. Link demonstrated experimental knowledge of the topic.

Question Title

The individual objectives/content topic were cohesive with one another.

Question Title

The content of the program was balanced and free of commercial bias.

Question Title

Speaker(s) fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Question Title

I would recommend this speaker for future conference.

T